EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Humoral and T-cell-mediated responses to an insect-specific flavivirus-based Zika virus vaccine candidate

Danielle L Porier, Awadalkareem Adam, Lin Kang, Pawel Michalak, Juselyn Tupik, Matthew A Santos, Manette Tanelus, Krisangel López, Dawn I Auguste, Christy Lee, Irving C Allen, Tian Wang und 1 weitere

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Danielle L Porier und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Entomology, Virginia Tech, Blacksburg, Virginia, United States of America. Hauptthemen laut MEDLINE: Zika Virus, Zika Virus Infection, Viral Vaccines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flaviviruses represent a significant global health threat and relatively few licensed vaccines exist to protect against them. Insect-specific flaviviruses (ISFVs) are incapable of replication in humans and have emerged as a novel and promising tool for flavivirus vaccine development. ISFV-based flavivirus vaccines have shown exceptional safety, immunogenicity, and efficacy, however, a detailed assessment of the correlates of protection and immune responses induced by these vaccines are still needed for vaccine optimization. Here, we explore the mechanisms of protective immunity induced by a previously created pre-clinical Zika virus (ZIKV) vaccine candidate, called Aripo/Zika (ARPV/ZIKV). In brief, immunocompromised IFN-αβR -/- mice passively immunized with ARPV/ZIKV immune sera experienced protection after lethal ZIKV challenge, although this protection was incomplete. ARPV/ZIKV-vaccinated IFN-αβR -/- mice depleted of CD4 + or CD8 + T-cells at the time of ZIKV challenge showed no morbidity or mortality. However, the adoptive transfer of ARPV/ZIKV-primed T-cells into recipient IFN-αβR -/- mice resulted in a two-day median increase in survival time compared to controls. Altogether, these results suggest that ARPV/ZIKV-induced protection is primarily mediated by neutralizing antibodies at the time of challenge and that T-cells may play a comparatively minor but cumulative role in the protection observed. Lastly, ARPV/ZIKV-vaccinated Tcra KO mice, which are deficient in T-cell responses, experienced significant mortality post-challenge. These results suggest that ARPV/ZIKV-induced cell-mediated responses are critical for development of protective immune responses at vaccination. Despite the strong focus on neutralizing antibody responses to novel flavivirus vaccine candidates, these results suggest that cell-mediated responses induced by ISFV-based vaccines remain important to overall protective responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika VirusZika Virus InfectionViral VaccinesAnimalsMiceAntibodies, ViralImmunity, CellularMice, KnockoutImmunity, HumoralAntibodies, NeutralizingMice, Inbred C57BLT-LymphocytesFlavivirusFemale

Substanzen

Viral VaccinesAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Entomology, Virginia Tech, Blacksburg, Virginia, United States of America.
  • Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
  • Department of Biomedical Research, Edward Via College of Osteopathic Medicine, Monroe, Louisiana, United States of America.
  • Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, United States of America.
  • College of Pharmacy, University of Louisiana Monroe, Monroe, Louisiana, United States of America.
  • Center for One Health Research, Virginia-Maryland College of Veterinary Medicine, Blacksburg, Virginia, United States of America.

ORCID-Profile: Albert J Auguste

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • NINDS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • National Institute of Food and Agriculture
  • George Washington Carver Fellowship, College of Agriculture and Life Sciences, Virginia Polytechnic Institute and State University
  • Gilliam Fellowship for Advanced Study, Howard Hughes Medical Institute

Zitieren

APA

Porier, D. L., Adam, A., Kang, L., Michalak, P., Tupik, J., Santos, M. A., Tanelus, M., López, K., Auguste, D. I., Lee, C., Allen, I. C., Wang, T., & Auguste, A. J. (2024). Humoral and T-cell-mediated responses to an insect-specific flavivirus-based Zika virus vaccine candidate. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012566

Vancouver

Porier DL, Adam A, Kang L, Michalak P, Tupik J, Santos MA, et al. Humoral and T-cell-mediated responses to an insect-specific flavivirus-based Zika virus vaccine candidate. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012566

BibTeX
@article{Porier2024,
  author = {Porier, Danielle L and Adam, Awadalkareem and Kang, Lin and Michalak, Pawel and Tupik, Juselyn and Santos, Matthew A and Tanelus, Manette and López, Krisangel and Auguste, Dawn I and Lee, Christy and Allen, Irving C and Wang, Tian and Auguste, Albert J},
  title = {Humoral and T-cell-mediated responses to an insect-specific flavivirus-based Zika virus vaccine candidate},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012566}
}
Kostenlos starten →